Expansion capital for enterprise technology and healthcare companies across North America
Opportunistic investments in traditional and alternative asset classes in pursuit of total return
Investing in private credit, special situations and private equity funds
Customized fixed income investment solutions for individuals, trusts and estates
A new paradigm for Opportunity Zone investing
Navigate back to website
Expansion capital for technology-enabled businesses and healthcare companies across North America
9/4/2024
An industry-leading meetings, events, and hospitality technology provider, today announced that it has acquired Splash, an event marketing technology company.
8/14/2024
Embedding Aware’s AI-Powered Collaboration Security Solution in Mimecast’s connected Human Risk Management platform will strengthen collaboration security and compliance offerings and accelerate innovation
3/20/2024
Greg Ho named a 2024 Notable Leaders in Finance by Crain’s New York Business.
1/24/2024
Vice President Jack Januszewski discusses SMC’s Social Impact strategy on the Opportunity Zones Podcast
7/11/2023
Genomenon Acquires Boston Genetics for Rapid Human Genome Curation.
11/14/2022
Maven Announces $90 Million Series E Financing led by General Catalyst.
11/11/2022
Recess raises $5 million in Series A funding led by Spring Mountain Capital and Data Point Capital.
10/4/2022
Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, today announced the close of a $21.5 million Series B financing.
7/21/2022
Keen Decision Systems (“Keen”) announced today that it has closed an $11 million Series B financing led by Ballast Point Ventures IV (“BPV”) to accelerate the industry’s first and only decision optimization engine rooted in predictive analytics
4/26/2022
Thentia raises $10 million Series B1 Financing led by Spring Mountain Capital and BDC Capital
3/10/2022
Genomenon raises $20 million Series B Financing led by Spring Mountain Capital and Beringea
3/2/2022
Everwash raises $6 million Series B Financing led by Spring Mountain Capital
2/16/2022
Eyrus raises $12 million Series A Financing led by Spring Mountain Capital and Autodesk
2/7/2022
Koneksa raises $45 million in Series C funding led by Matrix Capital Management
11/12/2021
ReNetX Bio Completes Enrollment of RESET Study of AXER-204 for Chronic Spinal Cord Injury
11/10/2021
11/9/2021
Spring Mountain Capital completes successful sale of OpenSlate to DoubleVerify for $150 million
10/13/2021
Aware raises $60 million in Series C funding led by Goldman Sachs
10/7/2021
IsoPlexis announces Pricing of Initial Public Offering
9/21/2021
Thentia Cloud becomes state-supported software provider for occupational licensing in Oklahoma
8/19/2021
RepairSmith raises $42 million in Series B funding led by Spring Mountain Capital, TI Capital, Mercedes-Benz, and Porsche Ventures
8/17/2021
Maven raises $110 million in Series D funding co-led by Dragoneer and Lux Capital at a $1 billion valuation
8/2/2021
Spring Mountain Capital completes successful sale of RiskSense to Ivanti
6/2/2021
Spring Mountain Capital completes successful sale of Home Captain to Volly
Thentia raises $10 million Series B Financing led by Spring Mountain Capital
4/21/2021
Spring Mountain Capital announces new Opportunity Zone strategy
3/18/2021
Spring Mountain Capital completes successful sale of 180 Health Partners to Mindoula
2/18/2021
Maven CEO Kate Ryder receives the Disruptive Founder of the Year award from Rock Health, Goldman Sachs, and Fenwick & West.
1/8/2021
Spring Mountain Capital completes successful sale of Oncoceutics to Chimerix
1/7/2021
IsoPlexis raises $135 million in Series D funding led by Perceptive Advisors
12/14/2020
Aware raises $12 million Series B Financing led by Spring Mountain Capital
12/9/2020
The Scientist names IsoPlexis single-cell intracellular proteome a Top 10 Innovation of 2020
10/13/2020
Spring Mountain Capital completes successful sale of Doctor.com to Press Ganey
9/29/2020
Konkesa raises $16 million Series B Financing led by Spring Mountain Capital
2/28/2020
Maven raises $45 million in Series C funding led by Icon Ventures
12/3/2019
Oncoceutics ONC201 featured in National Cancer Institute article "As Use of Genomic Data Expands in Cancer Care, Patients Share Their Stories"
11/27/2019
180 Health Partners featured on NPR podcast "In The Fight For Money For The Opioid Crisis, Will The Youngest Victims Be Left Out?"
9/18/2019
OpenSlate announces strategic investment by Nielsen to offer customers digital content-quality ratings
7/31/2019
Kate Ryder appears on NBC Today show to discuss how Maven is working to close the gap in women's wellness
6/19/2019
ReNetX Bio, Inc. announces U.S. FDA authorization to proceed for IND application to treat patients with Chronic Spinal Cord Injury
5/14/2019
IsoPlexis completes $25 million Series C financing
4/9/2019
Keen Decision Systems announces Series A investment from Spring Mountain Capital
2/15/2019
Oncoceutics licenses rights to ONC201 for Japan to Ohara Pharmaceutical
2/1/2019
Oncoceutics featured in People Magazine for its promise in treating brain tumors
1/22/2019
Spring Mountain Capital completes successful exit of Activate Healthcare
11/12/2018
FDA grants fast track designation to ONC201 for the treatment of Adult Recurrent H3 K27M-mutant High-Grade Glioma
9/26/2018
Maven raises $27 million in Series B funding led by Sequoia Capital and Oak HC/FT
8/7/2018
RiskSense raises $12 million in Series B funding round co-led by Spring Mountain Capital and NightDragon Security
6/22/2018
Utz Quality Foods treats employees with Activate Healthcare onsite healthcare clinic
6/13/2018
Doctor.com recognized by Google as the only Google My Business (GMB) partner focused on healthcare